Transdigm Group INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, reported a transaction in 3,900 shares of common stock on July 15, 2026.
NYSE
W Nicholas Howley, a Director of TransDigm Group INC, sold 10,132 shares of common stock on July 20, 2026.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 414 shares of common stock on July 15, 2026.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 3,486 shares of common stock on July 15, 2026.
NYSE
TransDigm Group Director W. Nicholas Howley files an amended Form 4 to correct administrative errors made by the filing agent, superseding previous duplicate filings.
NYSE
Form 4: TransDigm Director Sells Shares
W. Nicholas Howley, a Director at TransDigm Group Inc., reported the sale of common stock on May 18, 2026, through the W. Nicholas Howley Family Trust.
NYSE
Form 4: TransDigm Executive Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group Inc., reported the sale of common stock totaling 3,900 shares on May 15, 2026.
NYSE
Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group Inc. on April 20, 2026.
NYSE
TransDigm Group Co-Chief Operating Officer Joel Reiss exercised 3,900 stock options and subsequently sold the shares on April 15, 2026.
NYSE
TransDigm Group Director Peter Palmer acquired 30 shares of common stock valued at $36,439.80 in lieu of a semi-annual director fee.
NYSE
TransDigm Group Director Jane M. Cronin is scheduled to acquire 30 shares of common stock as part of her semi-annual director fee.
NYSE
TransDigm Group Director Sean Hennessy acquired 41 shares of common stock as part of his semi-annual director fee.
NYSE
TransDigm Group Director Gary McCullough acquired 37 shares of common stock in lieu of a semi-annual director fee, increasing his direct beneficial ownership to 952 shares.
NYSE
TransDigm Group Director David Barr acquired 41 shares of common stock valued at $1,214.66 per share as part of his semi-annual director fee.
NYSE
TransDigm Group Director Michael Graff acquired 30 shares of common stock at $1,214.66 per share as part of his semi-annual director fee.
NYSE
TransDigm Group Director W. Nicholas Howley acquired 113 shares of common stock in lieu of a director fee, increasing his direct beneficial ownership.
NYSE
TransDigm Group Director W. Nicholas Howley exercised stock options and subsequently sold common stock under a pre-arranged Rule 10b5-1 plan.
NYSE
TransDigm Group director Robert J. Small reported a purchase of one common stock share and resolved a Section 16(b) short-swing profit issue.
NYSE
TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, exercised stock options to acquire 1,460 shares of common stock.
NYSE
TransDigm Group's President and CEO, Michael Lisman, acquired 950 shares of common stock at $1,284.2608 per share, increasing his direct beneficial ownership.
NYSE
TransDigm Group's Chief Financial Officer, Sarah Wynne, exercised stock options to acquire 1,494 shares of common stock.
NYSE
TransDigm Group Director Kevin M. Stein sold 11,075 shares of common stock for approximately $15.9 million through a pre-arranged 10b5-1 plan.
NYSE
TransDigm Group director Kevin M. Stein exercised stock options and subsequently sold a significant portion of the acquired shares, as detailed in a recent SEC Form 4 filing.
NYSE
TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, exercised stock options and subsequently sold an equal number of common shares.
NYSE
TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold 3,900 shares of common stock in a pre-planned transaction.
NYSE
TransDigm Group Director Kevin M. Stein exercised stock options and subsequently sold a portion of the acquired common stock through a pre-arranged 10b5-1 plan.
NYSE
TransDigm Group Director Kevin M. Stein exercised stock options and subsequently sold an equivalent number of shares through a trust.
NYSE
TransDigm Group Director Kevin Stein executed pre-planned transactions, exercising stock options and selling an equivalent number of common shares.
NYSE
TransDigm Group's Co-Chief Operating Officer, Patrick Joseph Murphy, exercised stock options and subsequently sold an equal number of common shares.
NYSE
TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold a net of 120 common shares under a Rule 10b5-1 plan.